Subscribe to our newsletter and benefit from the latest news on cold chain logisticsRegister
Download the Product CatalogueDownload
There is a growing trend for bespoke treatments
and targeted therapies. The development of biological drugs is set to intensify
over the next 10 to 15 years, and yet these products are highly sensitive to temperature
variations. How is this challenge being handled in Europe and the United
medicines are developed using living plant, human or animal cells, or
micro-organisms. These complex, innovative molecules remain highly fragile and
are particularly sensitive to temperature
variations, with a limited shelf life. Even slight temperature variations
can modify the drugs’ molecular structure, and extreme care is required at
every stage in the supply chain.
At present, over 90% of vaccines require a temperature-controlled supply chain from the manufacturer right up to administration to the patient.
By 2018, it is expected that 49% of the world’s top 100 healthcare products will belong to the biotechnology category.
By 2020, it is estimated that 8 in 10 of the world’s best-selling drugs will need to be stored at between +2°C and +8°C.
Patients are beginning to realise the importance of protecting their temperature-sensitive medicines as they take them home from the pharmacy. They recognise the need for special care when transporting medicines, in the same way that they have already become accustomed to transporting refrigerated or frozen food products in isothermal bags.
Pharmacists have a major role to play, providing advice and information to patients.
So the use of cooling bags is taking off in Europe! They guarantee the integrity of the product. From the manufacturers’ point of view, they are also a great opportunity to boost brand loyalty: isothermal bags can be easily customised to feature their name and logo.
distribution of drugs works differently in the United States, where there are
three major distribution channels:
That means a greater number of stakeholders involved in providing healthcare to patients. Chain stores have everything to gain from promoting an image of quality and being seen to do everything in their power to protect patients’ health. And that includes distributing drugs in protective isothermal bags. Pharmaceutical firms are aware of the importance of this change, but the same cannot yet be said for the majority of patients… Watch this space!